Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

Conference Article| May 01 1997 Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma D. R. Anderson; D. R. Anderson 1IDEC Pharmaceuticals Corporation, 11011 Torreyana Road, San Diego, CA92121, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar A. Grillo-López; A. Grillo-López 1IDEC Pharmaceuticals Corporation, 11011 Torreyana Road, San Diego, CA92121, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar C. Varns; C. Varns 1IDEC Pharmaceuticals Corporation, 11011 Torreyana Road, San Diego, CA92121, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar K. S. Chambers; K. S. Chambers 1IDEC Pharmaceuticals Corporation, 11011 Torreyana Road, San Diego, CA92121, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar N. Hanna N. Hanna 1IDEC Pharmaceuticals Corporation, 11011 Torreyana Road, San Diego, CA92121, U.S.A. Search for other works by this author on: This Site PubMed Google Scholar Biochem Soc Trans (1997) 25 (2): 705–708. https://doi.org/10.1042/bst0250705 Article history Received: November 04 1996 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation D. R. Anderson, A. Grillo-López, C. Varns, K. S. Chambers, N. Hanna; Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans 1 May 1997; 25 (2): 705–708. doi: https://doi.org/10.1042/bst0250705 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Society Transactions Search Advanced Search Keywords: ADCC, antibody-dependent cellular toxicity, CDC, complement-dependent cytotoxicity, NHL, non-Hodgkin's lymphoma This content is only available as a PDF.